Sector Update: Healthcare Stocks Decline Tuesday Afternoon

01:58 PM EDT, 10/27/2026 (MT Newswires) -- Healthcare stocks were lower Tuesday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF (XLV) each down about 0.1%. The iShares Biotechnology ETF (IBB) rose 0.9%. In corporate news, Novo Nordisk (NVO) failed to convince a US judge to block Eli Lilly (LLY) from running weight-loss and diabetes drug ads it called false and misleading, multiple news outlets reported Tuesday, citing court proceedings. Novo shares were down 1.1%, and Lilly was fractionally lower. Novartis (NVS) shares rose 1.6% after the company reported Q3 core diluted EPS Tuesday of $2.46, up from $2.25 a year earlier and above the FactSet consensus of $2.27. Teva Pharmaceutical Industries (TEVA) shares rose 0.9% after its Teva Pharmaceuticals International unit said Tuesday it has completed the acquisition of assets from BioXcel Therapeutics, including global rights to BXCL501, for $57.5 million upfront and up to $67.5 million in contingent payments.